This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Sage Products can't undo cancellation of two chlorhexidine patents, US court rules

( April 15, 2025, 20:34 GMT | Official Statement) -- MLex Summary: In a precedential decision, the US Court of Appeals for the Federal Circuit affirmed the outcome of two inter partes reviews of Sage Products' US Patent Nos. 10,398,642 and 10,688,067. According to the panel, substantial evidence supports the Patent Trial and Appeal Board's conclusion that both patents are invalid as anticipated by prior art.See attached document....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections